methadone has been researched along with Mood Disorders in 20 studies
Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction.
6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.
Mood Disorders: Those disorders that have a disturbance in mood as their predominant feature.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Methadone-maintained pregnant patients with mood disorders have compromised treatment outcomes ( [1] )." | 7.75 | The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients. ( Chisolm, MS; Fitzsimons, H; Heil, SH; Jones, HE; O'Grady, KE; Tuten, M, 2009) |
| "This study examines prevalence rates for DSM-III-R anxiety and affective disorders in three follow-up samples of opioid addicts who were treated with methadone maintenance." | 5.08 | Psychiatric comorbidity: prevalence in methadone maintenance treatment. ( Haas, N; Huggins, N; Khuder, S; McLellan, AT; Milby, JB; Schumacher, JE; Sims, MK; Woody, G, 1996) |
| " Dole DD-RG) patients according to the following six discussion points: (1) Treatment of personality disorders during Methadone Maintenance Treatment (MMT); (2) Treatment of Mood Disorders during MMT; (3) Treatment of Anxiety Disorders during MMT; (4) Treatment of Psychotic Disorders during MMT; (5) Treatment of violence during MMT; (6) Treatment of Alcohol Use Disorder (AUD) during MMT." | 5.01 | What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients. ( Maremmani, AGI; Maremmani, I; Pacini, M, 2019) |
| "Methadone-maintained pregnant patients with mood disorders have compromised treatment outcomes ( [1] )." | 3.75 | The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients. ( Chisolm, MS; Fitzsimons, H; Heil, SH; Jones, HE; O'Grady, KE; Tuten, M, 2009) |
| "We report nine cases where fluoxetine (FX) (20 mg/day) was added to maintenance treatment with methadone (MTD) (dose range: 30-100 mg) in addicts with affective disorders." | 3.69 | Fluoxetine addition to methadone in addicts: pharmacokinetic aspects. ( Baumann, P; Bertschy, G; Eap, CB; Powell, K, 1996) |
| "This hyperalgesia is evident in people with a history of heroin use and is not modified by methadone or buprenorphine treatment but is reduced by long-term abstinence from opioids." | 1.32 | Pleasure into pain: the consequences of long-term opioid use. ( White, JM, 2004) |
| "Women with ASPD were unlikely to have alcohol use disorder, but likely to have opioid use disorder." | 1.30 | Gender differences in psychiatric comorbidity among cocaine-using opiate addicts. ( Foote, J; Handelsman, L; Kang, SY; Magura, S; Rosenblum, A, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 6 (30.00) | 18.2507 |
| 2000's | 10 (50.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maremmani, AGI | 1 |
| Pacini, M | 2 |
| Maremmani, I | 2 |
| Treloar, C | 1 |
| Holt, M | 1 |
| Popovic, D | 1 |
| Romano, A | 1 |
| Maremmani, AG | 1 |
| Perugi, G | 1 |
| Deltito, J | 1 |
| Akiskal, K | 1 |
| Akiskal, H | 1 |
| Tuten, M | 2 |
| Heil, SH | 1 |
| O'Grady, KE | 1 |
| Fitzsimons, H | 1 |
| Chisolm, MS | 1 |
| Jones, HE | 2 |
| Fischer, M | 1 |
| Reif, A | 1 |
| Polak, T | 1 |
| Pfuhlmann, B | 1 |
| Fallgatter, AJ | 1 |
| White, JM | 2 |
| Mitchell, TB | 1 |
| Dyer, KR | 1 |
| Newcombe, D | 1 |
| Salter, A | 1 |
| Somogyi, AA | 1 |
| Bochner, F | 1 |
| Seifert, J | 1 |
| Metzner, C | 1 |
| Paetzold, W | 1 |
| Borsutzky, M | 1 |
| Ohlmeier, M | 1 |
| Passie, T | 1 |
| Hauser, U | 1 |
| Becker, H | 1 |
| Wiese, B | 1 |
| Emrich, H | 1 |
| Schneider, U | 1 |
| Rachid, F | 1 |
| Golaz, J | 1 |
| Bondolfi, G | 1 |
| Bertschy, G | 3 |
| Fitzsimons, HE | 1 |
| Vaidya, V | 1 |
| Shi, J | 1 |
| Zhao, LY | 1 |
| Epstein, DH | 1 |
| Zhang, XL | 1 |
| Lu, L | 1 |
| Kanof, PD | 2 |
| Aronson, MJ | 2 |
| Ness, R | 2 |
| Baumann, P | 2 |
| Milby, JB | 1 |
| Sims, MK | 1 |
| Khuder, S | 1 |
| Schumacher, JE | 1 |
| Huggins, N | 1 |
| McLellan, AT | 1 |
| Woody, G | 1 |
| Haas, N | 1 |
| Eap, CB | 1 |
| Powell, K | 1 |
| Magura, S | 1 |
| Kang, SY | 1 |
| Rosenblum, A | 1 |
| Handelsman, L | 2 |
| Foote, J | 1 |
| Calsyn, DA | 1 |
| Wells, EA | 1 |
| Fleming, C | 1 |
| Saxon, AJ | 1 |
| Cochrane, KJ | 1 |
| Peachey, JE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| MOms in REcovery (MORE): Defining Optimal Care for Pregnant Women and Infants[NCT04251208] | 444 participants (Actual) | Observational | 2019-07-30 | Active, not recruiting | |||
| A Pilot Randomized Comparative Effectiveness Clinical Trial of Buprenorphine vs. Methadone for the Treatment of Opioid Dependence in Pregnancy.[NCT03098407] | 55 participants (Actual) | Interventional | 2017-04-20 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for methadone and Mood Disorders
| Article | Year |
|---|---|
What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients.
Topics: Alcoholism; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Craving; Drug Interactio | 2019 |
3 trials available for methadone and Mood Disorders
| Article | Year |
|---|---|
Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.
Topics: Adult; Anticonvulsants; Buprenorphine; Carbamazepine; Diagnostic and Statistical Manual of Mental Di | 2005 |
Psychiatric comorbidity: prevalence in methadone maintenance treatment.
Topics: Adult; Anxiety Disorders; Comorbidity; Female; Follow-Up Studies; Humans; Male; Methadone; Mood Diso | 1996 |
The dysphoria of heroin addiction.
Topics: Adolescent; Adult; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Mood Disorders; | 1992 |
16 other studies available for methadone and Mood Disorders
| Article | Year |
|---|---|
Drug treatment clients' readiness for hepatitis C treatment: implications for expanding treatment services in drug and alcohol settings.
Topics: Adolescent; Adult; Female; Health Care Surveys; Health Knowledge, Attitudes, Practice; Hepatitis C; | 2008 |
Affective temperaments in heroin addiction.
Topics: Adult; Alcoholism; Anxiety Disorders; Bipolar Disorder; Cohort Studies; Comorbidity; Cyclothymic Dis | 2009 |
The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Diagnosis, Dual (Psychiatry); Female; Genital | 2009 |
The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Diagnosis, Dual (Psychiatry); Female; Genital | 2009 |
The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Diagnosis, Dual (Psychiatry); Female; Genital | 2009 |
The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Diagnosis, Dual (Psychiatry); Female; Genital | 2009 |
False-positive methadone drug screens during quetiapine treatment.
Topics: Adult; Antipsychotic Agents; Cross Reactions; Dibenzothiazepines; False Positive Reactions; Female; | 2010 |
Pleasure into pain: the consequences of long-term opioid use.
Topics: Analgesics, Opioid; Drug Tolerance; Humans; Hyperalgesia; Methadone; Mood Disorders; Narcotics; Sens | 2004 |
Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure.
Topics: Adult; Area Under Curve; Blood Pressure; Female; Heart Rate; Humans; Isomerism; Male; Methadone; Mid | 2004 |
Induction of a mixed depressive episode during rTMS treatment in a patient with refractory major depression.
Topics: Adult; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive | 2006 |
Mood disorders affect drug treatment success of drug-dependent pregnant women.
Topics: Adult; Diagnosis, Dual (Psychiatry); Diagnostic and Statistical Manual of Mental Disorders; Female; | 2007 |
Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers.
Topics: Adult; Blood Pressure; China; Cues; Heart Rate; Heroin Dependence; Humans; Male; Methadone; Mood Dis | 2007 |
Receptor physiology and hormone secretion in affective illness.
Topics: Acetylcholine; Antidepressive Agents; Biogenic Amines; Blood Platelets; Depression; Humans; Methadon | 1983 |
Organic mood syndrome associated with detoxification from methadone maintenance.
Topics: Adult; Dose-Response Relationship, Drug; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Mo | 1993 |
Vulnerability to fluoxetine-induced indifference syndrome among opiate addicts: a case report.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Fluoxetine; Humans; Male; Meth | 1995 |
Fluoxetine addition to methadone in addicts: pharmacokinetic aspects.
Topics: Adult; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Drug Interactions; Female; Fluo | 1996 |
Gender differences in psychiatric comorbidity among cocaine-using opiate addicts.
Topics: Adult; Alcoholism; Anxiety Disorders; Cocaine-Related Disorders; Comorbidity; Female; Humans; Male; | 1998 |
Changes in Millon Clinical Multiaxial Inventory scores among opiate addicts as a function of retention in methadone maintenance treatment and recent drug use.
Topics: Adult; Antisocial Personality Disorder; Anxiety Disorders; Female; Follow-Up Studies; Humans; Male; | 2000 |
The role of drugs in the treatment of opioid addicts.
Topics: Alcoholism; Anxiety; Clonidine; Dextropropoxyphene; Heroin; Humans; Inactivation, Metabolic; Kinetic | 1986 |